Sponsor or institution
Clinical trials and research at Bioprovar Corporation
As of November 12, 2026, Find a Trial lists 4 NIH-funded research projects at this institution, with $1.4 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4NIH research projects
NIH-funded research (4)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Innovative immune therapy with antibiotics to treat deadly inflammation in sepsis and ARDS in older adults
A new approach combines an antibiotic strategy with a special immune-based treatment to help older patients who have sepsis or ARDS from severe bacterial infection.
-
A new immune-blocking therapy plus antibiotics for severe sepsis and ARDS in older adults
This project is trying a treatment that restores a natural TREM1 blocker together with antibiotics to help older adults with life-threatening bacterial sepsis or ARDS.
-
TREM1-targeted immune therapy to lower gut inflammation in older adults with ulcerative colitis
This project is developing a treatment that blocks the TREM1 inflammation pathway to reduce colon inflammation in older adults with ulcerative colitis.
-
Using immune therapy and antibiotics to treat severe inflammation in older patients with sepsis and ARDS.
This study is looking at a new way to help older adults with sepsis and severe breathing problems by using a mix of immune therapy and antibiotics, focusing on a special immune receptor that might help reduce harmful inflammation and improve their chances of recovery.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.